0      0

29th Annual North American Cystic Fibrosis Conference

W03: NT: Novel Targets & Outcome Measures

Oct 8, 2015 10:00am ‐ Oct 8, 2015 11:45am

Standard: $49.99


In this session, new therapeutic advances in both the clinical & basic science world will be presented. Clinicians & basic scientists alike will find value in the discussion about novel approaches to treat CF lung disease in addition to the presentation of outcome measures appropriate for young children.

Educational Objectives:

  1. Identify the latest advances in treatment focused on inflammation, gene therapy & mesenchymal stem cells currently under study for CF.
  2. Describe the applicability of lung clearance index as an outcome measure for lung disease progression in young children.
  3. Assess the impact ivacaftor & hormone fluctuations have on the trajectory of disease progression.


You must be logged in and own this session in order to post comments.